GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the kinase domain of the Q207E mutant of ACVR1 (ALK2) in complex with a 2-aminopyridine inhibitor K02288

Analyse Crystal structure of the kinase domain of the Q207E mutant of ACVR1 (ALK2) in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6EIX
Type
protein
Length
312 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Activin receptor type-1
EC
2.7.11.30
UniProt
Q04771
Ligands
A3F
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AActivin receptor type-1 (EC 2.7.11.30)protein31240% helix, 20% strandQ04771

Ligands and binding sites

  • A3F · 3-[6-amino-5-(3,4,5-trimethoxyphenyl)pyridin-3-yl]phenol · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 9 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14820.690.8049A3F, EDO
21290.540.8231EDO

Compared structures

  • 6EIX · Crystal structure of the kinase domain of the Q207E mutant of ACVR1 (ALK2) in complex… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q04771 · AlphaFold monomer V2.0 prediction for activin receptor type-1 (Q04771) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.